{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68998-939",
      "generic_name": "Cetirizine Hydrochloride",
      "labeler_name": "Marc Glassman, Inc.",
      "brand_name": "Cetirizine Hydrochloride",
      "active_ingredients": [
        {
          "name": "CETIRIZINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68998-939-30",
          "description": "30 TABLET in 1 BOTTLE (68998-939-30)",
          "marketing_start_date": "20121101",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Marc Glassman, Inc."
        ],
        "rxcui": [
          "1014678"
        ],
        "spl_set_id": [
          "f30900e6-425f-43e0-81b6-1fa3bd321f0b"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "64O047KTOA"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "1e5b54b1-a7d9-44ae-b2e5-0a77793ad13a",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20121101",
      "product_id": "68998-939_1e5b54b1-a7d9-44ae-b2e5-0a77793ad13a",
      "application_number": "ANDA077498",
      "brand_name_base": "Cetirizine Hydrochloride",
      "pharm_class": [
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}